Market Cap (In PLN)
167.41 Million
Revenue (In PLN)
1.39 Million
Net Income (In PLN)
-13.55 Million
Avg. Volume
1309.00
- Currency
- PLN
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 38.1-57.8
- PE
- -9.11
- EPS
- -3.94
- Beta Value
- 0.949
- ISIN
- PLPLTRG00038
- CUSIP
- -
- CIK
- -
- Shares
- 4663448.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Piotr Trzonkowsk
- Employee Count
- -
- Website
- https://poltreg.tech
- Ipo Date
- 2021-11-23
- Details
- Poltreg S.A., a biotechnology company, develops therapies for autoimmune diseases using T-regulatory cells. It engages in the research and development of therapies for the treatment of type 1 diabetes in children and in multiple sclerosis. The company is based in Gdansk, Poland.
More Stocks
-
ADMQADM Endeavors, Inc.
ADMQ
-
001231
-
GYLD-BGyldendal A/S
GYLD-B
-
AILLNAmeren Illinois Company
AILLN
-
SIPTL
-
2805S&B Foods Inc.
2805
-
VHAQ
-
9928